Program
Mechanism of Action
Indications
HitDiscovery
LeadDiscovery
Lead Optimization
Preclinical Candidate
IND
Phase I
Phase II
Status
CC002
CDK2
Breast Cancer
To be out-licensed
CC003
WRN
Solid Tumors
To be out-licensed
CC001
DGK
Solid Tumors
To be out-licensed
CC004
LRRK2
Parkinson
To be out-licensed
CC008
P53 Y220C
Solid Tumors
To be out-licensed
CC006
PARG
Solid Tumors
To be out-licensed
About us About Starg Management team Our Values
Research Pipeline
News Contact us

©Copyright2021 Starg (Wuhan) Pharmaceutical Tech Co Ltd. EICPB No. 2023031485